Lilly's Type 2 Diabetes Drug Trulicity Gets FDA Approval
19 September 2014 - 8:43AM
Dow Jones News
By Josh Beckerman
Eli Lilly & Co.'s (LLY) Type 2 diabetes drug Trulicity has
been approved by the U.S. Food and Drug Administration, the agency
said Thursday.
The drug is a subcutaneous injection that helps improve blood
sugar levels.
The FDA is requiring certain postmarketing studies for
Trulicity.
Write to Josh Beckerman at josh.beckerman@wsj.com
Access Investor Kit for Eli Lilly & Co.
Visit
http://www.companyspotlight.com/partner?cp_code=A591&isin=US5324571083
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From Apr 2024 to May 2024
Eli Lilly (NYSE:LLY)
Historical Stock Chart
From May 2023 to May 2024